Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03111316 · ClinicalTrials.gov registry record · NA
Foley Catheter Compared to the Foley Catheter Alone for Cervical Ripening
A NA study of Cervical Ripening and Induction of Labor, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT03111316: Completed NA study of Cervical Ripening and Induction of Labor, sponsored by University of Oklahoma.
NCT03111316 is a NA study of Cervical Ripening and Induction of Labor that has completed, run by University of Oklahoma. The registered enrollment target is 100 participants, below the 458-participant average among 8 other Cervical Ripening trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03111316, a NA study of Cervical Ripening and Induction of Labor, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
In term women presenting for labor induction, combined use of the controlled release dinoprostone vaginal insert and Foley catheter for cervical ripening will decrease the median time from induction to vaginal delivery by at least four hours compared to the Foley catheter alone.
Primary Outcome
median time estimation for use of dinoprostone and foley catheter and foley catheter alone
Conditions Studied
Interventions
- DEVICE Foley Catheter
- DRUG Cervidil 10 MG Vaginal Insert
Study Locations (1)
Oklahoma
- The University of Oklahoma Health Sciences Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-04-09 |
| Est. Completion | 2020-07-24 |
| Phase | NA |
What the finished NCT03111316 record still lists
NCT03111316 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 458-participant average among 8 other Cervical Ripening trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Cervical Ripening appearing as the primary indexed condition, and to 2 interventions - of which Foley Catheter is the first listed.
NCT03111316 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT03111316 about?
NCT03111316 is a clinical study titled "Foley Catheter Compared to the Foley Catheter Alone for Cervical Ripening". In term women presenting for labor induction, combined use of the controlled release dinoprostone vaginal insert and Foley catheter for cervical ripening will decrease the median time from induction to vaginal delivery by at least four hours compared to the Foley catheter alone.
What is the current status of trial NCT03111316?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2017-04-09. Estimated completion is 2020-07-24.
What conditions does trial NCT03111316 study?
This clinical trial studies the following conditions: Cervical Ripening, Induction of Labor.
What interventions are being tested in trial NCT03111316?
The interventions under investigation include: Foley Catheter (DEVICE), Cervidil 10 MG Vaginal Insert (DRUG).
Who is sponsoring clinical trial NCT03111316?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03111316 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Ripening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03111316's enrollment target sits among peer trials
100 7th of 8 higher than 2 of 8 other Cervical Ripening trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cervical Ripening trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor
COMPLETED · NA
-
Foley Bulb Traction for Cervical Ripening
COMPLETED · NA
-
Study of the Effectiveness of Cervical Ripening Balloon With and Without Oxytocin
COMPLETED · Phase 3
-
Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal Delivery
COMPLETED · Phase 3
-
Misoprostol Vaginal Insert (MVI) 100, 150, 200 mcg for Cervical Ripening and Induction of Labor
COMPLETED · Phase 2
-
Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study)
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI